• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤色素沉着作为口服甲氧沙林后最小光毒性剂量的预测指标。

Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.

作者信息

Bech-Thomsen N, Angelo H R, Wulf H C

机构信息

Department of Dermatology, Copenhagen University Hospital, Rigshopitalet, Denmark.

出版信息

Arch Dermatol. 1994 Apr;130(4):464-8.

PMID:8166483
Abstract

BACKGROUND AND DESIGN

Twenty-eight subjects were phototested to determine their erythemal responses to oral methoxsalen with UV-A and UV-B irradiation. Skin pigmentation was measured by skin reflectance at 550 and 660 nm before irradiation. The smallest UV radiation dose to produce erythema (minimal phototoxic dose and minimal erythema dose, respectively) was determined. The serum concentration of methoxsalen was measured at the time of UV-A irradiation.

RESULTS

There was a positive correlation between skin pigmentation and both 72-hour minimal phototoxic dose and 24-hour minimal erythema dose. No correlation was demonstrated between methoxsalen serum concentration and minimal phototoxic dose. The combination of skin pigmentation and methoxsalen level did not give a better prediction of minimal phototoxic dose than skin pigmentation alone.

CONCLUSIONS

Skin pigmentation measurements can be used to predict the minimal phototoxic and erythema doses. Skin pigmentation measurements are easy to perform and should be included in both phototherapy and photochemotherapy to improve the efficiency and reliability of the treatment.

摘要

背景与设计

对28名受试者进行光测试,以确定他们口服甲氧沙林后接受紫外线A和紫外线B照射时的红斑反应。在照射前,通过测量550和660纳米处的皮肤反射率来测定皮肤色素沉着。确定产生红斑的最小紫外线辐射剂量(分别为最小光毒性剂量和最小红斑剂量)。在紫外线A照射时测量甲氧沙林的血清浓度。

结果

皮肤色素沉着与72小时最小光毒性剂量和24小时最小红斑剂量之间呈正相关。甲氧沙林血清浓度与最小光毒性剂量之间未显示出相关性。皮肤色素沉着和甲氧沙林水平的组合对最小光毒性剂量的预测效果并不比单独的皮肤色素沉着更好。

结论

皮肤色素沉着测量可用于预测最小光毒性和红斑剂量。皮肤色素沉着测量易于进行,应纳入光疗和光化学疗法中,以提高治疗的效率和可靠性。

相似文献

1
Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.皮肤色素沉着作为口服甲氧沙林后最小光毒性剂量的预测指标。
Arch Dermatol. 1994 Apr;130(4):464-8.
2
A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.补骨脂素 - 紫外线A红斑与紫外线B红斑剂量 - 反应关系的比较。
Arch Dermatol. 1989 Dec;125(12):1653-7.
3
Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.用于评估皮肤癌风险以及对紫外线B和口服甲氧沙林光化学疗法急性反应的皮肤分型。
Arch Dermatol. 1984 Jul;120(7):869-73.
4
Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.采用漫反射光谱法测定V型和VI型皮肤个体的最小红斑量
Photodermatol Photoimmunol Photomed. 1994 Dec;10(6):249-54.
5
Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.含新型补骨脂素的凝胶和乳膏与浴用补骨脂素紫外线A疗法的光毒性比较
J Med Assoc Thai. 2005 Oct;88(10):1406-11.
6
The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.确定局部应用8-甲氧基补骨脂素致敏皮肤的最小光毒性剂量的最佳时间。
Br J Dermatol. 2004 Jul;151(1):179-82. doi: 10.1111/j.1365-2133.2004.06073.x.
7
Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.外用8-甲氧基补骨脂素致敏皮肤的红斑作用光谱重新评估:对常规临床实践的意义
Br J Dermatol. 2016 Jan;174(1):131-5. doi: 10.1111/bjd.14101. Epub 2015 Nov 14.
8
Cutaneous phototoxicity due to psoralens.补骨脂素引起的皮肤光毒性。
Natl Cancer Inst Monogr. 1984 Dec;66:117-26.
9
The effect of methoxsalen dose on ultraviolet-A-induced erythema.甲氧沙林剂量对紫外线A诱导红斑的影响。
J Invest Dermatol. 2001 May;116(5):813-5. doi: 10.1046/j.1523-1747.2001.01348.x.
10
Improved prediction of the minimal phototoxic dose in PUVA therapy.补骨脂素加紫外线A疗法中最小光毒性剂量预测的改进
Br J Dermatol. 1994 May;130(5):604-9. doi: 10.1111/j.1365-2133.1994.tb13107.x.

引用本文的文献

1
Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?氟喹诺酮类抗菌药物的副作用概述:新药与旧药对比,安全性方面是否有所进步?
Pharmaceutics. 2023 Mar 1;15(3):804. doi: 10.3390/pharmaceutics15030804.
2
Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment.药物反应中的种族和民族差异:走向个体化药物治疗
J Natl Med Assoc. 2002 Oct;94(10 Suppl):1-26.